Harrow Health (HROW) Misses Q1 EPS by 8c

Harrow Health (NASDAQ: HROW) reported Q1 EPS of ($0.28), $0.08 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $34.6 million versus the consensus estimate of $37.19 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Harrow study shows Iheezo cuts discomfort after eye injections
• Navios Maritime Partners (NMM) Tops Q2 EPS by 34c